4 terminated, 1 withdrawn. 5 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 4, Withdrawn 1 |
| Phase 1 | 3 | Terminated 3 |
Follow rociletinib: new trials by email Literature Review of rociletinib trials Research Report on rociletinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC) Rociletinib, Biopsy, Blood draw - Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer | Phase 2 | Withdrawn | Washington University School of Medicine | 2016-05-01 | 2016-05-17 | |
| A Phase 1b/2 Study of Safety and Efficacy of Rociletinib in Combination With MPDL3280A in Patients With Advanced or Metastatic EGFR-mutant NSCLC Rociletinib, MPDL3280A - Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Terminated | Clovis Oncology, Inc. | 3 | 2016-02-24 | 2019-07-05 |
| Phase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGFR-positive Advanced or Metastatic Non-small Cell Lung Cancer Rociletinib, Trametinib - Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Terminated | Clovis Oncology, Inc. | 7 | 2015-09-30 | 2018-10-02 |
| Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer Rociletinib - Non-small Cell Lung Cancer | Phase 2 | Terminated | Clovis Oncology, Inc. | 318 | 2014-06-16 | 2020-08-12 |
| Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients Rociletinib - Locally Advanced or Metastatic Non Small Cell Lung Cancer | Phase 1 / Phase 2 | Terminated | Clovis Oncology, Inc. | 612 | 2012-03-27 | 2020-08-04 |
Carcinoma, Non-Small-Cell Lung (5) · Neoplasm Metastasis (2) · Neoplasms (2) · Recurrence (2)
Clovis Oncology, Inc. (4) · Washington University School of Medicine (1)
United States (4) · Australia (2) · France (2) · Canada (1) · Germany (1) · Hong Kong (1) · Netherlands (1) · Poland (1) · South Korea (1) · Spain (1) · Switzerland (1) · Taiwan (1) · United Kingdom (1)
Lindsey Rolfe, MD (1) · Paula O'Connor, MD (1) · Saiama Waqar, M.D. (1)